Variable outcome of experimental interferon-γ therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12Rβ1- deficient Slovakian children

European Journal of Pediatrics

Volumn 164, Issue 3, 2005, Pages 166-172

  Ulrichs, Timo ^a,b   Fieschi, Claire ^c   Nevicka, Eva ^d   Hahn, Helmut ^b   Brezina, Martin ^d   Kaufmann, Stefan H E ^a   Casanova, Jean Laurent ^c   Frecerova, Klara ^d  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b Institute for Infection Medicine   (Germany)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Natl Inst of TB and Resp Diseases   (Slovakia)

Author keywords

BCG vaccination; Interferon ; Interleukin 12 receptor; Mycobacterial infection; Mycobacterium bovis BCG

Indexed keywords

BCG VACCINE; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 23; RECOMBINANT GAMMA INTERFERON; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BCG VACCINATION; CASE REPORT; DRUG RESPONSE; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; IMMUNOMODULATION; INFANT; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MILIARY TUBERCULOSIS; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION REACTION;

ANIMALS; ANTIVIRAL AGENTS; CATTLE; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; MYCOBACTERIUM BOVIS; RECEPTORS, INTERLEUKIN; SLOVAKIA; TUBERCULOSIS, BOVINE;

EID: 17644369666     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-004-1599-2     Document Type: Article

References (29)

1. Aksu G, Tirpan C, Cavusoglu C, Soydan S, Altare F, Casanova JL, Kutukculer N (2001) Mycobacterium fortuitumchelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. Pediatr Infect Dis J 20: 551-553
2. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432-1435
3. Altare F, Ensser A, Breiman A, Reichenbach J, Baghdadi JE, Fischer A, Emile JF, Gaillard JL, Meinl E, Casanova JL (2001) Interleukin-12 receptor beta I deficiency in a patient with abdominal tuberculosis. J Infect Dis 184: 231-236
4. Baily GV (1980) Tuberculosis prevention trial Madras: trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 72[Suppl]: 174
5. Caragol I, Raspall M, Fieschi C, Feinberg J, Larrosa MN, Hernandez M, Figueras C, Bertran JM, Casanova JL, Espanol T (2003) Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis 37: 302-306
6. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20: 581-620
7. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A (1995) Immunological conditions of children with BCG disseminated infection. Lancet 346: 581
8. Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, Stephan JL, Bernaudin F, Bordigoni P, Turck D, Lachaux A, Albertini M, Bourrillon A, Dommergues JP, Pocidalo MA, Le Deist F, Gaillard JL, Griscelli C, Fischer A (1996) Idiopathic disseminated Bacillus Calmette-Guerin infection: a French national retrospective study. Pediatrics 98: 774-778
9. Cleary AM, Tu W, Enright A, Giffon T, Dewaal-Malefyt R, Gutierrez K, Lewis DB (2003) Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency. J Immunol 170: 597-603
10. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV (1995) The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96: 29-35
11. De Jong R, Altare F, Haagen IA, Elferink DG, Boer T, Breda Vriesman PJ, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, Casanova JL, Ottenhoff TH (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280: 1435-1438
12. Doleckova V, Vilicky J, Sula L, Kubecova D (1977) Fatal generalized BCG histiocytosis. Tubercle 58: 13-18
13. Dorman SE, Holland SM (2000) Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 11: 321-333
14. Erdos Z, Cserhati E, Szabo I (1978) A recovered case of generalized BCG infection. Acta Paediatr Acad Sci Hung 19: 205-209
15. Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al Jumaah S, Raspall M, Silva Duarte AJ, Tuerlinckx D, Virelizier JL, Fischer A, Enright A, Bernhoft J, Cleary AM, Vermylen C, Rodriguez-Gallego C, Davies G, Blutters-Sawatzki R, Siegrist CA, Ehlayel MS, Novelli V, Haas WH, Levy J, Freihorst J, Al Hajjar S, Nadal D, De Moraes Vasconcelos D, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne DS, Abel L, Casanova JL (2003) Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 197: 527-535
16. Fine PE (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345
17. Fine PE (2001) BCG: the challenge continues. Scand J Infect Dis 33: 243-245
18. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P (1996) Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64: 16-22
19. Haveric D (1980) Complications following BCG vaccination with special reference to the site of application of vaccine (in Croatian). Plucne Bolesti Tuberk 32: 144-148
20. Kadasi L, Polakova H, Zatkova A, Kayserova H, Hruskovic I (1998) The spectrum of mutations in the CFTR gene in patients with cystic fibrosis in Slovakia (in Slovak). Bratisl Lek Listy 99: 33-36
21. Lichtenauer-Kaligis EG, de Boer T, Verreck FA, van Voorden S, Hoeve MA, van d Vosse, E, Ersoy F, Tezcan I, van Dissel JT, Sanal O, Ottenhoff TH (2003) Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur J Immunol 33: 59-69
22. Losana G, Rigamonti L, Borghi I, Assenzio B, Ariotti S, Jouanguy E, Altare F, Forni G, Casanova JL, Novelli F (2002) Requirement for both IL-12 and IFN-gamma signaling pathways in optimal IFN-gamma production by human T cells. Eur J Immunol 32: 693-700
23. Rodrigues LC, Diwan VK, Wheeler JG (1993) Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 22: 1154-1158
24. Seiler P, Ulrichs T, Bandermann S, Pradl L, Jorg S, Krenn V, Morawietz L, Kaufmann SH, Aichele P (2003) Cell-Wall alterations as an attribute of Mycobacterium tuberculosis in latent Infection. J Infect Dis 188: 1326-1331
25. Staretz-Haham O, Melamed R, Lifshitz M, Porat N, Fieschi C, Casanova JL, Levy J (2003) Interleukin-12 receptor beta1 deficiency presenting as recurrent Salmonella infection. Clin Infect Dis 37: 137-140
26. Sutherland I (1990) An assessment of the value of BCG vaccination in England and Wales. Pneumologie 44[Suppl 1]: 653-654
27. Trnka L, Dankova D, Svandova E (1994) Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis 75: 348-352
28. Tuberculosis Control Programme and Expanded Programme on Immunization (1986) Efficiacy of infant BCG immunization. Wkly Epidemiol Rec 61: 216-218
29. World Health Organization (2001) http://www.who.int/tb/publications/ global_report/en/